Suppr超能文献

皮肌炎的环境触发因素:一项叙述性综述。

Environmental triggers of dermatomyositis: a narrative review.

作者信息

Bax Christina E, Maddukuri Spandana, Ravishankar Adarsh, Pappas-Taffer Lisa, Werth Victoria P

机构信息

Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA.

Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Ann Transl Med. 2021 Mar;9(5):434. doi: 10.21037/atm-20-3719.

Abstract

Dermatomyositis (DM) is an autoimmune disease that affects the skin, lungs, and muscle. Although the pathogenesis of DM is not completely understood, several environmental triggers have been linked to DM onset or flare. This article specifically examines the effects of herbal supplements, drugs, infections, ultraviolet (UV) radiation, and environmental pollutants on the onset or exacerbation of DM. Herbal supplements such as , , , , and Alfalfa have been implicated and are frequently used in health foods. Medications such as hydroxyurea, TNF-α inhibitors, immune checkpoint inhibitors (ICI), and penicillamine, as well as certain viral infections, such as parvovirus B19, coxsackie virus, polyomavirus, Epstein-Barr virus (EBV), hepatitis, influenza, and human immunodeficiency viruses (HIV) have been associated with DM onset. Bacterial infections and vaccinations have also been linked to the development of DM. Additional environmental factors, including UV radiation and air pollutants, such as silica, biological/mineral dust, and particulate air matter from vehicle and industrial emissions, may also play a role in DM pathogenesis. Overall, there is general agreement that an autoimmune attack of the skin, muscle, and lungs in DM can be triggered by various environmental factors and warrants further investigation.

摘要

皮肌炎(DM)是一种影响皮肤、肺部和肌肉的自身免疫性疾病。尽管DM的发病机制尚未完全明确,但已有多种环境触发因素与DM的发病或病情发作有关。本文具体探讨草药补充剂、药物、感染、紫外线(UV)辐射及环境污染物对DM发病或病情加重的影响。诸如 、 、 、 以及苜蓿等草药补充剂已被牵涉其中,且常用于保健食品中。诸如羟基脲、肿瘤坏死因子-α抑制剂、免疫检查点抑制剂(ICI)及青霉胺等药物,以及某些病毒感染,如细小病毒B19、柯萨奇病毒、多瘤病毒、爱泼斯坦-巴尔病毒(EBV)、肝炎病毒、流感病毒及人类免疫缺陷病毒(HIV)均与DM发病有关。细菌感染及疫苗接种也与DM的发生有关。其他环境因素,包括紫外线辐射及空气污染物,如二氧化硅、生物/矿物粉尘以及来自车辆和工业排放的颗粒物,也可能在DM发病机制中发挥作用。总体而言,人们普遍认为,DM中皮肤、肌肉和肺部的自身免疫攻击可由多种环境因素触发,值得进一步研究。

相似文献

1
Environmental triggers of dermatomyositis: a narrative review.
Ann Transl Med. 2021 Mar;9(5):434. doi: 10.21037/atm-20-3719.
2
The effects of immunostimulatory herbal supplements on autoimmune skin diseases.
J Am Acad Dermatol. 2021 Apr;84(4):1051-1058. doi: 10.1016/j.jaad.2020.06.037. Epub 2020 Jun 15.
3
Activation of autoimmunity following use of immunostimulatory herbal supplements.
Arch Dermatol. 2004 Jun;140(6):723-7. doi: 10.1001/archderm.140.6.723.
4
Herbal supplement Spirulina stimulates inflammatory cytokine production in patients with dermatomyositis .
iScience. 2023 Oct 28;26(11):108355. doi: 10.1016/j.isci.2023.108355. eCollection 2023 Nov 17.
5
A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes.
J Cutan Pathol. 2000 Nov;27(10):505-15. doi: 10.1034/j.1600-0560.2000.027010505.x.
6
Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
J Clin Virol. 2010 Dec;49(4):290-5. doi: 10.1016/j.jcv.2010.08.015. Epub 2010 Oct 8.
8
Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story.
Viruses. 2021 Feb 11;13(2):277. doi: 10.3390/v13020277.
9
The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum.
Cureus. 2022 Mar 8;14(3):e22978. doi: 10.7759/cureus.22978. eCollection 2022 Mar.
10
Dermatomyositis: Current concepts.
Clin Dermatol. 2018 Jul-Aug;36(4):450-458. doi: 10.1016/j.clindermatol.2018.04.003. Epub 2018 Apr 12.

引用本文的文献

1
2
Rapid Progression of Dermatomyositis in an Elderly Patient With Oropharyngeal and Pulmonary Involvement: A Case Report.
Cureus. 2025 May 17;17(5):e84267. doi: 10.7759/cureus.84267. eCollection 2025 May.
3
Myositis Due to Parvovirus B19: A Case Report and Literature Review.
Cureus. 2025 May 7;17(5):e83683. doi: 10.7759/cureus.83683. eCollection 2025 May.
4
Influenza knowledge and barriers to vaccination in immunosuppressed patients in the pediatric rheumatology clinic.
Pediatr Rheumatol Online J. 2024 Dec 18;22(1):104. doi: 10.1186/s12969-024-01048-1.
5
and Combined Extracts Cause Immunomodulatory Effects in Lipopolysaccharide-Challenged Rats.
Plants (Basel). 2024 Dec 3;13(23):3397. doi: 10.3390/plants13233397.
6
Occupational and Hobby Exposures Associated With Myositis Phenotypes in a National Myositis Patient Registry.
Arthritis Care Res (Hoboken). 2025 Jan;77(1):104-115. doi: 10.1002/acr.25461.
7
Recent Updates on the Pathogenesis of Inflammatory Myopathies.
Curr Rheumatol Rep. 2024 Dec;26(12):421-430. doi: 10.1007/s11926-024-01164-7. Epub 2024 Sep 24.
9
The relationship between infectious agents and juvenile dermatomyositis: a narrative update from the pediatric perspective.
Front Immunol. 2024 Apr 10;15:1377952. doi: 10.3389/fimmu.2024.1377952. eCollection 2024.
10
Dermatomyositis: Practical Guidance and Unmet Needs.
Immunotargets Ther. 2024 Mar 6;13:151-172. doi: 10.2147/ITT.S381472. eCollection 2024.

本文引用的文献

1
Frequency of immunostimulatory herbal supplement use among patients with autoimmune skin disease.
J Am Acad Dermatol. 2022 Nov;87(5):1093-1095. doi: 10.1016/j.jaad.2021.12.050. Epub 2022 Jan 6.
3
Toripalimab-Induced Dermatomyositis in a Patient with Metastatic Melanoma.
Dermatol Ther (Heidelb). 2020 Aug;10(4):863-867. doi: 10.1007/s13555-020-00396-6. Epub 2020 May 22.
4
Dermatomyositis Induced by Filler Rhinoplasty Using Liquid Silicone.
JAMA Otolaryngol Head Neck Surg. 2020 Feb 1;146(2):205-206. doi: 10.1001/jamaoto.2019.3629.
6
Geospatial Correlation of Amyopathic Dermatomyositis With Fixed Sources of Airborne Pollution: A Retrospective Cohort Study.
Front Med (Lausanne). 2019 Apr 24;6:85. doi: 10.3389/fmed.2019.00085. eCollection 2019.
7
Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors.
Nat Rev Drug Discov. 2018 Nov 28;17(12):854-855. doi: 10.1038/nrd.2018.210.
8
Wong-type dermatomyositis during anti-PD-1 therapy.
JAAD Case Rep. 2018 Nov 10;4(10):1049-1051. doi: 10.1016/j.jdcr.2018.08.006. eCollection 2018 Nov.
9
Pembrolizumab-induced dermatomyositis in a patient with metastatic melanoma.
Eur J Cancer. 2018 Nov;104:227-230. doi: 10.1016/j.ejca.2018.08.021. Epub 2018 Oct 12.
10
Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
Br J Dermatol. 2019 Sep;181(3):580-583. doi: 10.1111/bjd.17245. Epub 2018 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验